| Literature DB >> 29226140 |
Alejandra Mendoza-Cantú1, Víctor Hugo Urrutia-Baca2, Cynthia Sofía Urbina-Ríos2, Myriam Angélica De la Garza-Ramos3, Martha Elena García-Martínez1, Hilda H H Torre-Martínez4.
Abstract
The variability in Helicobacter pylori vacA and cagA genes has been related to the progression of the gastrointestinal disease; also the presence of H. pylori in the oral cavity has been associated with periodontal disease in adults, but, in children without dyspeptic symptoms, little is known about this. We evaluated the prevalence of H. pylori and the presence of vacA/cagA genotypes in the oral cavity of Mexican children without dyspeptic symptoms. The gingival status was measured, and dental plaque samples (n = 100) were taken. 38% of children were positive for H. pylori 16S rRNA gene by qPCR. A significant association between H. pylori oral infection and gingival status was observed (P < 0.001). In 34.6% (9/26) of mild gingivitis cases, s1m2 genotype was found, while s1m1 was typed in 50% (3/6) of moderate gingivitis. The cagA prevalence among H. pylori-positive children was 80.8% (21/26), 83.3% (5/6), and 16.7% (1/6) of cases of mild gingivitis, moderate gingivitis, and nongingivitis, respectively (P < 0.001). The s1m1/cagA+ combinational genotype was the most detected in children with gingivitis. Our results suggest that the prevalence of H. pylori and detection of vacA/cagA genotypes-associated gastrointestinal disease in the oral cavity could be related to the progression of gingivitis in asymptomatic children.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29226140 PMCID: PMC5687131 DOI: 10.1155/2017/4923640
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
PCR primers and probes used for detection and genotyping of H. pylori.
| Gen | 5′-3′ sequence | Product size | Reference |
|---|---|---|---|
| 16S rRNA | F: GATAGTCAGTCAGGTGTGAAATCC | 196 | In this study |
| R: GTTTGCTCCCCACGCTTT | |||
| Probe: AAAATCCGTAGAGATCAAGAGGA | |||
|
| F: GACCGACTCGATCAAATAGCA | 113 | |
| R: TTAGCTGAAAGCCCTACCTTAC | |||
| Probe: AGTGGTTTGGGTGATGTAGGGCAA | |||
|
| |||
|
| vacA1F: CTGGT(C/T)TAAAGTCGCACCCTTTGTGC |
| Koehler et al. [ |
| vacA1R: CAATGGCTGGAATGATCACGGTTGT(A/G) | |||
| vacA2F: CAAACACACCGCAAAATCAATCGCCC | |||
|
| m1F1: CAACAATCAAGGCACTATCAA(C/T)TA | 301 | |
| m1R1: CCGCATGCTTTAATGTCATCAG | |||
| m1F2: TGGTCCGAGGCGGG(A/C)AAGT | |||
| m1R2: TCATCAGTATTTCGCACCACAC | |||
|
| m2F1: TTTGGAGC(C/T)CCAGGAAACATTG | 102 | |
| m2R1: C(C/T)ACACGCCCATCTTGGACAA | |||
| m2F2: ACCCTAAA(C/T)AGCAACGCAAGC | |||
| m2R2: GACAAAAAGATTCATCGTGCCTT | |||
Figure 1Results of the gel electrophoresis for identification of H. pylori vacA alleles and genotypes in dental plaque samples of Mexican children. (a) Detection of s alleles. Lane M, molecular weight marker 0.1 to 10 kb (BioLabs Inc.); lane 1, positive control (DNA from H. pylori ATCC 43504 s1m1 genotype); lanes 2-3, positive control (DNA from gastric biopsy with H. pylori s2m2 genotype); lane 4, negative control (without DNA); lane 5, s2 allele positive (DNA from sample); lane 6, s1 allele positive (DNA from sample); lane 7, s1 and s2 alleles positive (DNA from sample). (b) Detection of m1 allele. Lane M, molecular weight marker 0.1 to 10 kb (BioLabs Inc.); lane 1, positive control (DNA from H. pylori ATCC 43504 s1m1 genotype); lane 2, negative control (without DNA); lane 3, m1 allele negative (DNA from sample); lanes 4–7, m1 allele positive (DNA from sample). (c) Detection of m2 alleles. Lane M, molecular weight marker 0.1 to 10 kb (BioLabs Inc.); lane 1, positive control (DNA from gastric biopsy with H. pylori vacA s2m2 genotype); lane 2, negative control (without DNA); lanes 3 and 7, m2 allele negative (DNA from sample); lanes 4–6, m2 allele positive (DNA from sample).
Prevalence of H. pylori in dental plaque from Mexican children by gender and age and the gingival clinical presentation.
| Total |
|
| ||
|---|---|---|---|---|
| Positive | Negative | |||
|
| ||||
| Female | 50 (50.0) | 17 (44.7) | 33 (53.2) | 0.41a |
| Male | 50 (50.0) | 21 (55.3) | 29(46.8) | |
|
| ||||
| Mean (±SD) | 8.95 (±3.72) | 8.37 (±4.17) | 9.31 (±3.4) | 0.2425b |
|
| ||||
| 3–5 | 21 (21.0) | 12 (31.6) | 9 (14.5) | 0.084a |
| 6–8 | 33 (33.0) | 10 (26.3) | 23 (37.1) | |
| 9–11 | 14 (14.0) | 2 (5.3) | 12 (19.4) | |
| 12–14 | 26 (26.0) | 12 (31.6) | 14 (22.6) | |
| 15-16 | 6 (6.0) | 2 (5.3) | 4 (6.5) | |
|
| ||||
| No inflammation | 59 (59.0) | 6 (15.8) | 53 (85.5) | <0.001c |
| Mild inflammation | 35 (35.0) | 26 (68.4) | 9 (14.5) | |
| Moderate inflammation | 6 (6.0) | 6 (15.8) | 0 | |
aChi-square test. bStudent's t test. cExact Fisher test. MGI: modified gingival index.
Distribution of the gingival clinical presentation by gender and age.
| Modified gingival index |
| |||
|---|---|---|---|---|
| No inflammation | Mild inflammation | Moderate inflammation | ||
|
| ||||
| Female | 32 (54.2) | 13 (37.1) | 5 (83.3) | 0.078a |
| Male | 27 (45.8) | 22 (62.1) | 1 (16.7) | |
|
| ||||
| Mean (±SD) | 9.47 (±3.42) | 8.77 (±4.02) | 4.83 (±2.04) | 0.012b |
|
| ||||
| 3–5 | 8 (13.6) | 10 (28.6) | 3 (50.0) | 0.135a |
| 6–8 | 22 (37.3) | 8 (22.9) | 3 (50.0) | |
| 9–11 | 11 (18.6) | 3 (8.6) | 0 | |
| 12–14 | 14 (23.7) | 12 (34.3) | 0 | |
| 15-16 | 4 (6.8) | 2 (5.7) | 0 | |
aExact Fisher test. bOne-way ANOVA test.
Distribution of vacA genotypes, cagA status, and combinational vacA/cagA genotypes in dental plaque from H. pylori-positive children with gingival clinical presentation.
| Total |
| |||
|---|---|---|---|---|
| No inflammation | Mild inflammation | Moderate inflammation | ||
|
a
| ||||
| | 31 (81.6) | 3 (50.0) | 22 (84.6) | 6 (100.0) |
| | 10 (26.3) | 3 (50.0) | 6 (23.1) | 1 (16.7) |
| | 24 (63.2) | 4 (66.7) | 15 (57.7) | 5 (83.3) |
| | 16 (42.1) | 1 (16.7) | 13 (50.0) | 2 (33.3) |
| | 3 (7.9) | 1 (16.7) | 2 (7.7) | 0 |
|
| ||||
| | 10 (26.3) | 1 (16.7) | 6 (23.1) | 3 (50.0) |
| | 11 (28.9) | 1 (16.7) | 9 (34.6) | 1 (16.7) |
| | 6 (15.8) | 3 (50.0) | 3 (11.5) | 0 |
| | 2 (5.3) | 1 (16.7) | 1 (3.8) | 0 |
| | 1 (2.6) | 0 | 1 (3.8) | 0 |
| b | 5 (13.2) | 0 | 4 (15.4) | 1 (16.7) |
| b | 3 (7.9) | 0 | 2 (7.7) | 1 (16.7) |
|
| ||||
| Positive | 27 (71.1) | 1 (16.7) | 21 (80.8) | 5 (83.3) |
| Negative | 11 (28.9) | 5 (83.3) | 5 (19.2) | 1 (16.7) |
|
| ||||
| | 9 (23.7) | 1 (16.7) | 5 (19.2) | 3 (50.0) |
| | 1 (2.6) | 0 | 1 (3.8) | 0 |
| | 5 (13.2) | 0 | 5 (19.2) | 0 |
| | 5 (13.2) | 1 (16.7) | 3 (11.5) | 1 (16.7) |
| | 4 (10.5) | 0 | 4 (15.4) | 0 |
| | 3 (7.9) | 3 (50.0) | 0 | 0 |
| | 4 (10.5) | 0 | 3 (11.5) | 1 (16.7) |
| | 3 (7.9) | 0 | 2 (7.7) | 1 (16.7) |
| | 1 (2.6) | 0 | 1 (3.8) | 0 |
| cUndetermined | 3 (7.9) | 1 (16.7) | 2 (7.7) | 0 |
aFrequency and percentages based on H. pylori-positive patients. bCoexistence of genotypes; cvacA genotypes with m0 alleles; m0: nontypeable for middle region.